$DAVA stockholders filed a claim against Endava for misleading them about falling demand and canceled projects. After the financial resul...

$STM stockholders filed a claim against STMicroelectronics for misleading them with overly optimistic revenue forecasts and lacking the i...

$DXCM stockholders filed a claim against DexCom for misleading them about its financial prospects and hiding problems with the salesforce...

$ARDX stockholders filed a claim against Ardelyx for misleading them about the prospects and success of its drug. After the news on July ...

$STLA stockholders filed a claim against Stellantis for misleading them about its 2024 financial outlook, despite providing positive upda...

$EXTR stockholders filed a claim against Extreme Networks for hiding that its backlog fell faster than expected due to pandemic over-orde...

$ICU stockholders filed a claim against SeaStar Medical for overstating FDA approval chances for SCD and hiding financial issues. After t...

$SYM stockholders filed a claim against Symbotic for misleading them about its growth and expenses. After the financial results on July 2...

$EQUI-VEST investors filed a claim against Equitable Financial for hiding the true costs of its EQUI-VEST variable annuities. EQUI-VEST i...

$RELX stockholders filed a claim against RELX Group for misleading about its commitment to ESG standards. RELX investors can join this c...

$CXM stockholders filed a claim against Sprinklr for hiding issues and slow growth in its core products. After the financial results on J...

$INDV stockholders filed a claim against Indivior for overstating its ability to predict new laws' impact, revenue, and 2024 targets. Aft...

$MRNA stockholders filed a claim against Moderna for misleading them about the effectiveness of its vaccine, overstating its potential. A...

$F stockholder filed a claim against Ford Motor for hiding quality issues since 2022, which led to higher warranty costs and profit risks...

$MORF stockholder filed a claim against Morphic Holding to block its merger with Lilly until issues are fixed or, if it proceeds, to seek...